A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, Walter J., Tschöpe, Carsten·2013·Journal of the American College of Cardiology
Cited by (1,005)
Items 301–400 of 1,005
- Immunometabolic mechanisms of heart failure with preserved ejection fractionGabriele G. Schiattarella, Pilar Alcaide, Gianluigi Condorelli, Thomas G. Gillette, Stephane R B Heymans, Elizabeth A. V. Jones, Marinos Kallikourdis, Andrew H. Lichtman, Federica M. Marelli‐Berg, Sanjiv Jayendra Shah et al. · 2022 · Nature Cardiovascular Research
- Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectivesvan Woerden, Gijs, van Veldhuisen, Dirk J., Westenbrink, B. Daan, de Boer, Rudolf A., Rienstra, Michiel, Gorter, Thomas M. · 2022 · European Journal of Heart Failure
- Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic PotentialRoman Roy, Joshua Wilcox, Andrew J. Webb, Kevin O’Gallagher · 2023 · International Journal of Molecular Sciences
- Heart Failure With Preserved Ejection Fraction Expert Panel ReportKishan S. Parikh, Kavita Sharma, Mona Fiuzat, Howard K. Surks, Jyothis Thomas George, Narimon Honarpour, Christophe Depré, Patrice M. Desvigne-Nickens, Richard Nkulikiyinka, Gregory D. Lewis et al. · 2018 · JACC Heart Failure
- Cardiac changes associated with vascular agingNarayana Sarma V. Singam, Christopher Fine, Jerome L. Fleg · 2019 · Clinical Cardiology
- Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endotheliumDonato Cappetta, Antonella De Angelis, Loreta Pia Ciuffreda, Raffaele Coppini, Anna Cozzolino, Agostino Miccichè, Carmela Dell’Aversana, Domenico D’Amario, Eleonora Cianflone, Cristina Scavone et al. · 2020 · Pharmacological Research
- Key inflammatory mechanisms underlying heart failureChristian Riehle, Johann K Bauersachs · 2019 · Herz
- Macrophages and Cardiovascular HealthVanessa Frodermann, Matthias Nahrendorf · 2018 · Physiological Reviews
- Evidence of microvascular dysfunction in heart failure with preserved ejection fractionJoshua F. Lee, Zachary Barrett‐O’Keefe, Ryan S. Garten, Ashley D. Nelson, John Jake Ryan, Jose N. Nativi, Russell S. Richardson, David Walter Wray · 2015 · Heart
- Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection FractionWalter J. Paulus, Elisa Dal Canto · 2017 · JACC Heart Failure
- Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fractionMauro Gori, Michele Senni, Deepak K. Gupta, David M. Charytan, Elisabeth Kraigher‐Krainer, Burkert Mathias Pieske, Brian Lee Claggett, Amil M. Shah, Ângela Barreto Santiago Santos, Michael R. Zile et al. · 2014 · European Heart Journal
- Cardiac Contractility Modulation: Mechanisms of Action in Heart Failure with Reduced Ejection Fraction and BeyondCarsten Tschöpe, Behrouz Kherad, Oliver Klein, Axel Lipp, Florian Blaschke, David D. Gutterman, Daniel Burkhoff, Nazha Hamdani, Frank Spillmann, Sophie Van Linthout · 2018 · European Journal of Heart Failure
- Characteristics, Treatments and 1-Year Prognosis of Hospitalized and Ambulatory Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the European Society of Cardiology Heart Failure Long-Term RegistryMarco Canepa, Ewa Straburzyńska‐Migaj, Jarosław Dróżdż, Carla Fernández‐Vivancos, José Manuel García Pinilla, Noémi Nyolczas, Pier Luigi Temporelli, Alexandre Mebazaa, Mitja Lainščak, Cécile Laroche et al. · 2017 · European Journal of Heart Failure
- Liver Fibrosis Score Predicts Mortality in Heart Failure Patients with Preserved Ejection FractionAkiomi Yoshihisa, Yu Sato, Tetsuro Yokokawa, Takamasa Sato, Satoshi Suzuki, Masayoshi Oikawa, Atsushi Kobayashi, Takayoshi Yamaki, Hiroyuki Kunii, Kazuhiko Nakazato et al. · 2017 · ESC Heart Failure
- Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular diseaseXiaochen He, Heng Zeng, Jian‐Xiong Chen · 2018 · Journal of Cellular Physiology
- Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunctionFan Dong, Abhijit R Takawale, Ratnadeep Basu, Vaibhav B. Patel, Jiwon Lee, Vijay Kandalam, Xiuhua Wang, Gavin Y. Oudit, Zamaneh Kassiri · 2014 · Cardiovascular Research
- Pathophysiology of heart failure and frailty: a common inflammatory origin?Lavanya Bellumkonda, Daniel J. Tyrrell, Scott L. Hummel, Daniel R. Goldstein · 2017 · Aging Cell
- Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection FractionJasper Tromp, Mohsin A.F. Khan, Robert John Mentz, Christopher M. O’Connor, Marco Metra, Howard C. Dittrich, Piotr P. Ponikowski, John R. Teerlink, Gad Cotter, Beth A. Davison et al. · 2017 · JACC Heart Failure
- Retinal microvascular dysfunction in heart failureMatthias P. Nägele, Jens Barthelmes, Valeria Ludovici, Silviya Cantatore, Arnold von Eckardstein, Frank Enseleit, Thomas Felix Lüscher, Frank Thomas Ruschitzka, Isabella Sudano, Andreas J. Flammer · 2017 · European Heart Journal
- Heart Failure Risk Associated With Rheumatoid Arthritis–Related Chronic InflammationMichael J. Ahlers, Brandon D. Lowery, Eric H. Farber‐Eger, Thomas J. Wang, William S. Bradham, Michelle J. Ormseth, Cecilia P. Chung, Christoph Stein, Deepak K. Gupta · 2020 · Journal of the American Heart Association
- Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical EffectsGiuseppe Palmiero, Arturo Cesaro, Erica Vetrano, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Elisabetta Moscarella, Felice Gragnano, Teresa Salvatore, Luca Rinaldi et al. · 2021 · International Journal of Molecular Sciences
- Epidemiology of Heart FailureFrancesco Orso, Gianna Fabbri, Aldo Pietro Maggioni · 2016 · Handbook of experimental pharmacology
- Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trialAlexander Peikert, Muthiah Vaduganathan, Brian Lee Claggett, Ian J. Kulac, Sheldon E. Litwin, Michael R. Zile, Akshay Suvas Desai, Pardeep S. Jhund, Jawad H. Butt, Carolyn S.P. Lam et al. · 2025 · European Heart Journal
- Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection FractionMei Methawasin, Joshua G. Strom, Rebecca E. Slater, Vanessa Fernandez, Chandra Saripalli, Henk L. M. Granzier · 2016 · Circulation
- Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical OutcomeKatherine W Lam, Kenneth W. Chow, Jonathan C. Vo, Wei Hou, Haifang Li, Paul S. Richman, Sandeep K. Mallipattu, Hal A. Skopicki, Adam J. Singer, Timothy Q. Duong · 2020 · The Journal of Infectious Diseases
- Cardiosphere-Derived Cells Reverse Heart Failure With Preserved Ejection Fraction in Rats by Decreasing Fibrosis and InflammationRomain Gallet, Geoffrey de Couto, Eli Simsolo, Jackelyn Valle, Baiming Sun, Weixin Liu, Eleni Tseliou, Michael R. Zile, Eduardo Marbán · 2016 · JACC Basic to Translational Science
- Chronic low‐grade inflammation in heart failure with preserved ejection fractionThássio Mesquita, Yen‐Nien Lin, Ahmed Gamal-Eldin Ibrahim · 2021 · Aging Cell
- Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in PathophysiologyBrendan Nicholas Putko, Zuocheng Wang, Jennifer Lo, Todd J. Anderson, Harald H. Becher, Jason R.B. Dyck, Zamaneh Kassiri, Gavin Y. Oudit, on behalf of the Alberta HEART Investigators · 2014 · PLoS ONE
- Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection FractionBarry A. Borlaug · 2013 · Circulation Journal
- Differential Pathophysiological Mechanisms in Heart Failure With a Reduced or Preserved Ejection Fraction in DiabetesMilton Packer · 2021 · JACC Heart Failure
- A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular diseaseMicha Tobias Maeder, Otto Dagobert Schoch, Hans Rickli · 2016 · Vascular Health and Risk Management
- Preoperative systemic inflammation and perioperative myocardial injury: prospective observational multicentre cohort study of patients undergoing non-cardiac surgeryGareth L. Ackland, Tom E.F. Abbott, David J Cain, Mark Edwards, Pervez Sultan, Shamir N. Karmali, Alexander James Fowler, John Whittle, N.J. MacDonald, Anna Reyes et al. · 2018 · British Journal of Anaesthesia
- Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?Asmaa Elrakaybi, Katharina Laubner, Qian Zhou, Martin Johannes Hug, Jochen Seufert · 2022 · Molecular Metabolism
- The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?Beata Zaborska, Małgorzata Sikora-Frąc, Krzysztof Smarż, Ewa Pilichowska‐Paszkiet, Andrzej Budaj, Dariusz Sitkiewicz, Grażyna Sygitowicz · 2023 · International Journal of Molecular Sciences
- Novel sGC Stimulators and sGC Activators for the Treatment of Heart FailureStefanie Breitenstein, Lothar Roessig, Peter Sandner, Kelly S. Lewis · 2016 · Handbook of experimental pharmacology
- Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi‐Ethnic Study of Atherosclerosis)Daniel A. Duprez, Myron D. Gross, Jorge R. Kizer, Joachim H. Ix, William Gregory Hundley, David R. Jacobs · 2018 · Journal of the American Heart Association
- The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failureNicola Riccardo Pugliese, Stefano Masi, Stefano Taddei · 2019 · Heart Failure Reviews
- Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanismsKeming Huang, Xianling Luo, Bin Liao, Guang Li, Jian Feng · 2023 · Cardiovascular Diabetology
- Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection FractionDaniel Dalos, Julia Mascherbauer, Caroline Zotter‐Tufaro, Franz Duca, Andreas Anselm Kammerlander, Stefan Aschauer, Diana Bonderman · 2016 · Journal of the American College of Cardiology
- SIRT5‐Related Desuccinylation Modification Contributes to Quercetin‐Induced Protection against Heart Failure and High‐Glucose‐Prompted Cardiomyocytes Injured through Regulation of Mitochondrial Quality SurveillanceXing Chang, Tian Zhang, Junyan Wang, Yan Liu, Peizheng Yan, Qingyan Meng, Yongtian Yin, Shiyuan Wang · 2021 · Oxidative Medicine and Cellular Longevity · Retracted
- Influence of Epicardial and Visceral Fat on Left Ventricular Diastolic and Systolic Functions in Patients After Myocardial InfarctionRicardo Fontes‐Carvalho, Marta Fontes Oliveira, Francisco Sampaio, Jennifer Mâncio, Nuno Bettencourt, Madalena Teixeira, Francisco Rocha Gonçalves, Vasco Gama, Adelino Ferreira Leite-Moreira · 2014 · The American Journal of Cardiology
- Impact of General and Central Adiposity on Ventricular-Arterial Aging in Women and MenPeter Wohlfahrt, Margaret M. Redfield, Francisco Alejandro López-Jiménez, Vojtěch Melenovský, Garvan C. Kane, Richard J. Rodeheffer, Barry A. Borlaug · 2014 · JACC Heart Failure
- Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Randomized Clinical TrialStavros Stavrakis, Khaled Elkholey, Lynsie M. Morris, Monika Niewiadomska, Zain Ul Abideen Asad, Mary Beth Humphrey · 2022 · Journal of the American Heart Association
- Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity—Pathogenesis and Involvement of the Extracellular MatrixJagoda Kruszewska, Agnieszka Cudnoch‐Jędrzejewska, Katarzyna Czarzasta · 2022 · International Journal of Molecular Sciences
- Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fractionRoy, Clotilde, Slimani, Alisson, de Meester, Christophe, Amzulescu, Mihaela, Pasquet, Agnes, Vancraeynest, David, Beauloye, Christophe, Vanoverschelde, Jean-Louis, Gerber, Bernhard L., Pouleur, Anne-Catherine · 2018 · Journal of Cardiovascular Magnetic Resonance
- Association between Use of Statins and Mortality in Patients with Heart Failure and Ejection Fraction of ≥50%Alehagen, Urban, Benson, Lina, Edner, Magnus, Dahlström, Ulf, Lund, Lars H. · 2015 · Circulation Heart Failure
- Cardiac Disorders and Pathophysiology of Sarcomeric ProteinsJolanda van der Velden, Ger J.M. Stienen · 2018 · Physiological Reviews
- Inflammation in Metabolic CardiomyopathyFlorian A. Wenzl, Samuele Ambrosini, S A Mohammed, Simon C Kraler, Thomas Felix Lüscher, Sarah Costantino, Francesco Paneni · 2021 · Frontiers in Cardiovascular Medicine
- Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCAPasquale Paolisso, Alberto Foà, Luca Bergamaschi, Francesco Angeli, Michele Fabrizio, Francesco Donati, Sebastiano Toniolo, Chiara Chiti, Andrea Rinaldi, Andrea Stefanizzi et al. · 2021 · Cardiovascular Diabetology
- Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implicationsPankaj Garg, Rebecca C. Gosling, Peter Swoboda, Rachel S. Jones, Alexander M.K. Rothman, Jim M. Wild, David Gerard Kiely, Robin A Condliffe, Samer Alabed, Andrew J. Swift · 2022 · European Heart Journal
- Inflammation in Obesity-Related HFpEFSubodh Verma, Mark Colquhoun Petrie, Barry A. Borlaug, Javed Butler, Melanie Jane Davies, Dalane W. Kitzman, Sanjiv Jayendra Shah, Cecilia Rönnbäck, Steen Zabell Abildstrom, Karoline Liisberg et al. · 2024 · Journal of the American College of Cardiology
- Role of Biomarkers in Cardiac Structure Phenotyping in Heart Failure with Preserved Ejection Fraction: Critical Appraisal and Practical UseEmilia D’Elia, Muthiah Vaduganathan, Mauro Gori, Antonello Gavazzi, Javed Butler, Michele Senni · 2015 · European Journal of Heart Failure
- Mineralocorticoid Receptor Antagonism Treats Obesity-Associated Cardiac Diastolic DysfunctionShawn B. Bender, Vincent Gerard DeMarco, Jaume Padilla, Nathan T. Jenkins, Javad Habibi, Mona Garro, Lakshmi Pulakat, Annayya Rao Aroor, Iris Zamir Jaffe, James R. Sowers · 2015 · Hypertension
- Heart failure with preserved ejection fraction: controversies, challenges and future directionsRosita Zakeri, Martín Cowie · 2018 · Heart
- Macrophages in Heart Failure with Reduced versus Preserved Ejection FractionMatthew DeBerge, Sanjiv Jayendra Shah, Lisa D. Wilsbacher, Edward Benjamin Thorp · 2019 · Trends in Molecular Medicine
- Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac AmyloidosisDiana Michels da Silva, Harald F. Langer, Tobias Graf · 2019 · International Journal of Molecular Sciences
- Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and futureJan Wintrich, Ingrid Kindermann, Christian Ukena, Simina‐Ramona Selejan, Christian M. Werner, Christoph Maack, Ulrich Laufs, Carsten Tschöpe, Stefan D. Anker, Carolyn S.P. Lam et al. · 2020 · Clinical Research in Cardiology
- Characteristics of Hospitalizations for Heart Failure with Preserved Ejection FractionParag Goyal, Zaid Almarzooq, Evelyn M. Horn, Maria G. Karas, Irina Sobol, Rajesh V. Swaminathan, Dmitriy N. Feldman, Robert M. Minutello, Harsimran Sachdeva Singh, Geoffrey W. Bergman et al. · 2016 · The American Journal of Medicine
- The actions of relaxin on the human cardiovascular systemMohsin Sarwar, Xiao‐Jun Du, Thomas Bernd Dschietzig, Roger J. Summers · 2016 · British Journal of Pharmacology
- An Integrative Translational Approach to Study Heart Failure with Preserved Ejection Fraction: A Position Paper from the Working Group on Myocardial Function of the European Society of CardiologyAndré Pedro Lourenço, Adelino Ferreira Leite-Moreira, Jean‐Luc Balligand, Johann K Bauersachs, Dana K. Dawson, Rudolf A. de Boer, León J. De Windt, Inês Falcão‐Pires, Ricardo Fontes‐Carvalho, Stefan Franz et al. · 2017 · European Journal of Heart Failure
- Soluble GC stimulators and activators: Past, present and futurePeter Sandner, Markus Follmann, Eva Becker‐Pelster, Michael G. Hahn, Christian Meier, Cecilia Freitas, Lothar Roessig, Johannes‐Peter Stasch · 2021 · British Journal of Pharmacology
- Signaling cascades in the failing heart and emerging therapeutic strategiesXin He, Tailai Du, Tianxin Long, Xinxue Liao, Yugang Dong, Zhan‐Peng Huang · 2022 · Signal Transduction and Targeted Therapy
- Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and DiabetesPasquale Mone, Angela Lombardi, Urna Kansakar, Fahimeh Varzideh, Stanislovas S. Jankauskas, Antonella Pansini, Stefania Marzocco, Stefano De Gennaro, Michele Famiglietti, Gaetano Macina et al. · 2022 · Journal of Pharmacology and Experimental Therapeutics
- Diabetic microvascular disease in non-classical beds: the hidden impact beyond the retina, the kidney, and the peripheral nervesDı́dac Mauricio, Mónica Gratacòs, Josep Franch‐Nadal · 2023 · Cardiovascular Diabetology
- MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathwayJibo Han, Chunpeng Zou, Liqin Mei, Yali Zhang, Yuanyuan Qian, Shengban You, Yong Pan, Zheng Xu, Bin Bai, Weijian Huang et al. · 2016 · Basic Research in Cardiology
- Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic ProfilingWynn G. Hunter, Jacob P. Kelly, Robert W. McGarrah, William E. Kraus, Svati Hasmukh Shah · 2016 · Current Heart Failure Reports
- Novel heart failure biomarkers: why do we fail to exploit their potential?Arnold Piek, Weijie Du, Rudolf A. de Boer, Herman H.W. Silljé · 2018 · Critical Reviews in Clinical Laboratory Sciences
- ROS signalling between endothelial cells and cardiac cellsMin Zhang, Ajay M. Shah · 2014 · Cardiovascular Research
- Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial FibrillationThomas M. Gorter, Joost P. van Melle, Michiel Rienstra, Barry A. Borlaug, Yoran M. Hummel, Isabelle C. Van Gelder, Elke S. Hoendermis, Adriaan A. Voors, Dirk Jan van Veldhuisen, Carolyn S.P. Lam · 2017 · Journal of Cardiac Failure
- Neuroinflammation in heart failure: new insights for an old diseaseHugo S. Díaz, Camilo Toledo, David Cristobal Andrade, Noah Justin Marcus, Rodrigo Del Río · 2019 · The Journal of Physiology
- Heart failure with preserved ejection fraction: Refocusing on diastoleAntonio Abbate, Ross A Arena, Nayef Antar Abouzaki, Benjamin Wallace Van Tassell, Justin McNair Canada, Keyur B. Shah, Giuseppe Biondi‐Zoccai, Norbert Felix Voelkel · 2014 · International Journal of Cardiology
- Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic OptionsSalvatore, Teresa, Galiero, Raffaele, Caturano, Alfredo, Vetrano, Erica, Loffredo, Giuseppe, Rinaldi, Luca, Catalini, Christian, Gjeloshi, Klodian, Albanese, Gaetana, Di Martino, Anna et al. · 2022 · Biomedicines
- Albuminuria Is Independently Associated With Cardiac Remodeling, Abnormal Right and Left Ventricular Function, and Worse Outcomes in Heart Failure With Preserved Ejection FractionDaniel H. Katz, Jacob A. Burns, Frank G. Aguilar, Lauren Beussink‐Nelson, Sanjiv Jayendra Shah · 2014 · JACC Heart Failure
- Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem.Bharathi Upadhya, Mark J. Haykowsky, Joel Eggebeen, Dalane W. Kitzman · 2015 · Europe PMC (PubMed Central)
- Precision Medicine for Heart Failure with Preserved Ejection Fraction: An OverviewSanjiv Jayendra Shah · 2017 · Journal of Cardiovascular Translational Research
- The Prognostic Value of Highly Sensitive Cardiac Troponin Assays for Adverse Events in Men and Women with Stable Heart Failure and a Preserved vs. Reduced Ejection FractionAisha Gohar, Jenny P C Chong, Oi Wah Liew, Hester M. den Ruijter, Dominique P.V. de Kleijn, David Sim, Daniel Yeo, Hean Yee Ong, Fazlur Rehman Jaufeerally, Gerard Kui Toh Leong et al. · 2017 · European Journal of Heart Failure
- Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection FractionMichael S. Sabbah, Ahmed U. Fayyaz, Simon de Denus, Gary Michael Felker, Barry A. Borlaug, Surendra Dasari, Rickey E. Carter, Margaret M. Redfield · 2020 · Circulation Heart Failure
- SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in DiabetesXiaoqian Wu, Huan Liu, Alan C. Brooks, Suowen Xu, Jinque Luo, Rebbeca Steiner, Deanne M. Mickelsen, Christine Schomisch Moravec, Jeffrey D. Alexis, Eric M. Small et al. · 2022 · Circulation Research
- The Microenvironment of the Pathogenesis of Cardiac HypertrophyFarhad Bazgir, Julia Nau, Saeideh Nakhaei‐Rad, Ehsan Amin, Matthew J. Wolf, Jeffry J. Saucerman, Kristina Lorenz, Mohammad Reza Ahmadian · 2023 · Cells
- Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF PhenotypeKosiborod, Mikhail N., Abildstrøm, Steen Z., Borlaug, Barry A., Butler, Javed, Christensen, Louise, Davies, Melanie, Hovingh, Kees G., Kitzman, Dalane W., Lindegaard, Marie L., Møller, Daniél Vega et al. · 2023 · JACC: Heart Failure
- Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a Mouse model of Western diet induced obesityBrian Bostick, Javad Habibi, Lixin Ma, Annayya Rao Aroor, Nathan Rehmer, Melvin Ray Hayden, James R. Sowers · 2014 · Metabolism
- Understanding heart failure with preserved ejection fraction: where are we today?Loek van Heerebeek, Walter J. Paulus · 2016 · Netherlands Heart Journal
- Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?David Charles Hutchings, Simon George Anderson, Jessica L. Caldwell, Andrew W. Trafford · 2018 · Heart
- Heart Failure with Preserved Ejection Fraction: Diagnosis and ManagementOhad Oren, Sheldon Goldberg · 2017 · The American Journal of Medicine
- Metabolic Effects of Metformin in the Failing HeartAleksandra Dziubak, Grażyna Wójcicka, Andrzej Wojtak, Jerzy Bełtowski · 2018 · International Journal of Molecular Sciences
- Sympathetic and renin-angiotensin-aldosterone system activation in heart failure with preserved, mid-range and reduced ejection fractionGiuseppe Vergaro, Alberto Aimo, Concetta Prontera, Nicolò Ghionzoli, Chiara Arzilli, Luc Zyw, Claudia Taddei, Alessandra Gabutti, Roberta Poletti, Alberto Giannoni et al. · 2019 · International Journal of Cardiology
- The Future of Heart Failure Diagnosis, Therapy, and ManagementJames E. Udelson, Lynne Warner Stevenson · 2016 · Circulation
- Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection FractionRosita Zakeri, Gilles Moulay, Qiang Chai, Ozgur Ogut, Saad Hussain, Hiroyuki Takahama, Tong Lü, Xiao-Li Wang, Wolfgang Albrecht Linke, Hon-Chi Lee et al. · 2016 · Circulation Heart Failure
- The Ratio Between Visceral and Subcutaneous Abdominal Fat Assessed by Computed Tomography Is an Independent Predictor of Mortality and Cardiac EventsRicardo Ladeiras‐Lopes, Francisco Sampaio, Nuno Bettencourt, Ricardo Fontes‐Carvalho, Nuno Dias Ferreira, Adelino Ferreira Leite-Moreira, Vasco Gama · 2016 · Revista Española de Cardiología (English Edition)
- Adiponectin resistance in skeletal muscle: Pathophysiological implications in chronic heart failureSente, Tahnee, Van Berendoncks, An M, Hoymans, Vicky Y, Vrints, Christiaan J · 2016 · Journal of Cachexia, Sarcopenia and Muscle
- Effects of ranolazine in a model of doxorubicin‐induced left ventricle diastolic dysfunctionDonato Cappetta, Grazia Esposito, Raffaele Coppini, Elena Piegari, Rosa Russo, Loreta Pia Ciuffreda, Alessia Rivellino, Lorenzo Santini, Concetta Rafaniello, Cristina Scavone et al. · 2017 · British Journal of Pharmacology
- Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosisChao Ma, Huan Luo, Lei Fan, Xiaoyan Liu, Chengshan Gao · 2020 · Brazilian Journal of Medical and Biological Research
- Rehabilitation Intervention in Older Patients With Acute Heart Failure With Preserved Versus Reduced Ejection FractionRobert John Mentz, David J. Whellan, Gordon R. Reeves, Amy M. Pastva, Pamela Woods Duncan, Bharathi Upadhya, Michael Benjamin Nelson, Haiying Chen, Shelby D. Reed, Paul B. Rosenberg et al. · 2021 · JACC Heart Failure
- Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic TargetsJens van de Wouw, Michelle Broekhuizen, Oana Sorop, Jaap A. Joles, Marianne Christina Verhaar, Dirk Jan Duncker, A.H. Jan Danser, Daphne Merkus · 2019 · Frontiers in Physiology
- Machine Learning-Derived Echocardiographic Phenotypes Predict Heart Failure Incidence in Asymptomatic IndividualsMasatake Kobayashi, Olivier Huttin, Martin Magnusson, João Pedro Ferreira, Erwan Bozec, Anne-Cécile Huby, Grégoire Preud’homme, Kévin Duarte, Zohra Lamiral, Kévin Dalleau et al. · 2021 · JACC. Cardiovascular imaging
- Psoriasis and Risk of Heart Failure: A Nationwide Cohort StudyUsman Khalid, Ole Ahlehoff, Gunnar Gislason, Søren Lund Kristensen, Lone Skov, Christian Tobias Torp-Pedersen, Peter Riis Hansen · 2014 · European Journal of Heart Failure
- Prevention of the Development of Heart Failure with Preserved Ejection Fraction by the Phosphodiesterase-5A Inhibitor Vardenafil in Rats with Type 2 DiabetesCsaba Mátyás, Balázs Tamás Németh, Attila Oláh, Marianna Török, Mihály Ruppert, Dalma Kellermayer, Bálint András Barta, Gabor B. Szabo, Gábor Kökény, Eszter Maria Horvath et al. · 2016 · European Journal of Heart Failure
- Evolution of a Geriatric Syndrome: Pathophysiology and Treatment of Heart Failure with Preserved Ejection FractionBharathi Upadhya, Barbara Pisani, Dalane W. Kitzman · 2017 · Journal of the American Geriatrics Society
- Altered mitochondrial metabolism in the insulin‐resistant heartMarina Makrecka‐Kuka, Edgars Liepinsh, Andrew J. Murray, Hélène Lemieux, Maija Dambrova, Kersti Tepp, Marju Puurand, Tuuli Käämbre, Woo Hyun Han, Paul de Goede et al. · 2019 · Acta Physiologica
- Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical OutcomesAlexander Е. Berezin, Alexander A. Berezin, Michael Lichtenauer · 2021 · Disease Markers